Home Berkeley Law Library -- Reference & Research Services Ars Technica » Scientific Method Most new, high-priced cancer drugs don’t even extend life for 10 weeks

Most new, high-priced cancer drugs don’t even extend life for 10 weeks

Ars Technica » Scientific Method 2017-02-11

Summary:

Patient advocates are urging FDA and drug companies to set the bar higher.

Link:

https://arstechnica.com/science/2017/02/most-new-high-priced-cancer-drugs-dont-even-extend-life-for-10-weeks/

From feeds:

Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method

Tags:

cancer

Authors:

Beth Mole

Date tagged:

02/11/2017, 10:37

Date published:

02/10/2017, 11:16